Royalty Pharma plc - 3 year dividend growth rate
Dividend history for stock RPRX (Royalty Pharma plc) including dividend growth rate predictions based on history.
| Year | Dividend | Estimated Yield on Cost |
|---|---|---|
| 2034 | 1.821USD * | 6.50% |
| 2033 | 1.690USD * | 6.03% |
| 2032 | 1.568USD * | 5.60% |
| 2031 | 1.455USD * | 5.20% |
| 2030 | 1.350USD * | 4.82% |
| 2029 | 1.253USD * | 4.47% |
| 2028 | 1.163USD * | 4.15% |
| 2027 | 1.079USD * | 3.85% |
| 2026 | 1.001USD * | 3.58% |
| 2025 | 0.929USD * | 3.32% |
| 2024 | 0.862USD * | 3.08% |
| 2023 | 0.800USD | |
| 2022 | 0.760USD | |
| 2021 | 0.680USD | |
| 2020 | 0.300USD |
* These yearly dividends are calculated as current last years dividends times conservative dividend growth rate. Conservative dividend growth rate is calculated from DGR3 value and uses this function (in RPRX case 7.76% was used as conservative DGR).
RPRX
Price: $28
Dividend Yield: 0.03%
Forward Dividend Yield: 3.00%
Payout Ratio: 215.38%
Dividend Per Share: 0.84 USD
Earnings Per Share: 2.53 USD
P/E Ratio: 73.59
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Ebitda: -16.0 millionMarket Capitalization: 17.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 5
DGR3: 7.76%